Viewing Study NCT02389920


Ignite Creation Date: 2025-12-25 @ 4:26 AM
Ignite Modification Date: 2026-03-15 @ 4:35 PM
Study NCT ID: NCT02389920
Status: UNKNOWN
Last Update Posted: 2015-03-17
First Post: 2015-03-11
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Multicenter, Phaseâ…£, Open Label Trial of Nilotinib in Adult Patients Diagnosed Philadelphia Chromosome Positive(Ph+) Chronic Myeloid Leukemia in CP/AP Intolerant to Dasatinib
Sponsor: Samsung Medical Center
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2015-04
Start Date Type: None
Primary Completion Date: 2018-02
Primary Completion Date Type: ESTIMATED
Completion Date: 2018-12
Completion Date Type: ESTIMATED
First Submit Date: 2015-03-11
First Submit QC Date: None
Study First Post Date: 2015-03-17
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2015-03-16
Last Update Post Date: 2015-03-17
Last Update Post Date Type: ESTIMATED